✦ LIBER ✦

Renal function and safety of heart transplant recipients switched to mycophenolate mofetil and low-dose cyclosporine

✍ Scribed by M Baryalei; D Zenker; B Pieske; K Tondo; H Dalichau; I Aleksic

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erythrocyte sodium lithium countertransp

✍ K. Vareesangthip; P. Hanlakorn; L. Suwannaton; R. Larpkitkachorn; D. Chuawattana 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Elective withdrawal of mycophenolate mof

✍ C. G. ter Meulen; L. B. Hilbrands; P. J. H. Smak Gregoor; W. Weimar 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 378 KB

Elective withdrawal of mycophenolate mof

✍ Cornelis G. ter Meulen; Peter J. H. Smak Gregoor; Willem Weimar; Luuk B. Hilbran 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 49 KB

Primary immunosuppression with tacrolimu

✍ S. Yeung; W.K. Tsang; K.L. Tong; S.H. Wong; W. Lee; H.L. Tang; H.W.H. Chan; A.Y. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Safety and efficacy of mycophenolate mof

✍ S.M Suhail; A Vathsala; H.X Lou; K.T Woo 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Introduction of mycophenolate mofetil an

✍ G Dureau; J.F Obadia; M Chuzel; P Boissonnat 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 95 KB